|
US3686412A
(en)
|
1965-03-25 |
1972-08-22 |
Colin Fitzmaurice |
Compositions containing bis-chromonyl compounds for inhibiting antigen-antibody reactions
|
|
GB1144905A
(en)
|
1965-03-25 |
1969-03-12 |
Fisons Pharmaceuticals Ltd |
Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
|
|
US3957965A
(en)
|
1967-08-08 |
1976-05-18 |
Fisons Limited |
Sodium chromoglycate inhalation medicament
|
|
GB1242211A
(en)
|
1967-08-08 |
1971-08-11 |
Fisons Pharmaceuticals Ltd |
Pharmaceutical composition
|
|
GB1257162A
(enExample)
|
1968-02-16 |
1971-12-15 |
|
|
|
US4405598A
(en)
|
1976-01-30 |
1983-09-20 |
Fisons, Limited |
Composition for treating asthma
|
|
DE3104294A1
(de)
|
1981-02-07 |
1982-08-19 |
Hoechst Ag, 6000 Frankfurt |
Substituierte diazaspirodecane, ihre herstellung, ihre verwendung als stabilisatoren fuer organische polymere, sowie die so stabilisierten polymeren
|
|
US4429545A
(en)
|
1981-08-03 |
1984-02-07 |
Ocean & Atmospheric Science, Inc. |
Solar heating system
|
|
BE897058A
(fr)
|
1982-06-25 |
1983-12-16 |
Sandoz Sa |
Utilisation d'un derive du spiro-succinimide dans le traitement de la demence du type alzheimer
|
|
US4996296A
(en)
|
1983-07-27 |
1991-02-26 |
Yeda Research & Development Co., Ltd. |
Cromolyn binding protein in highly purifed form, and methods for the isolation thereof
|
|
US5231170A
(en)
|
1986-08-27 |
1993-07-27 |
Paul Averback |
Antibodies to dense microspheres
|
|
US4919915A
(en)
|
1987-03-03 |
1990-04-24 |
Paul Averback |
Method for detecting the ability to prevent red-to-green congophilic birefringence
|
|
CA2058764A1
(en)
|
1989-04-28 |
1990-10-29 |
Peter D. Hodson |
Dry powder inhalation device
|
|
US5376386A
(en)
|
1990-01-24 |
1994-12-27 |
British Technology Group Limited |
Aerosol carriers
|
|
DE4405387A1
(de)
|
1994-02-19 |
1995-08-24 |
Hoechst Ag |
Verfahren zur Herstellung von Polyalkyl-1-oxa-diazaspirodecan-Verbindungen
|
|
US6168776B1
(en)
|
1994-07-19 |
2001-01-02 |
University Of Pittsburgh |
Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
|
|
TR199600329A2
(tr)
|
1995-05-05 |
1997-03-21 |
Hoffmann La Roche |
Seker alkollerin yeni sülfürik asit esterleri.
|
|
US6026809A
(en)
|
1996-01-25 |
2000-02-22 |
Microdose Technologies, Inc. |
Inhalation device
|
|
US6126919A
(en)
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
|
KR100575070B1
(ko)
|
1997-09-29 |
2006-05-03 |
넥타르 테라퓨틱스 |
안정화된 생활성 제제 및 이의 사용 방법
|
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
|
US5904937A
(en)
|
1997-10-03 |
1999-05-18 |
Fmc Corporation |
Taste masked pharmaceutical compositions
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
KR100561223B1
(ko)
|
1998-06-12 |
2006-03-15 |
마이크로도스 테크놀로지즈 인코포레이티드 |
약제 및 약물의 계량, 포장 및 운송
|
|
US6197963B1
(en)
|
1998-08-13 |
2001-03-06 |
The Trustees Of The University Of Pennsylvania |
Non-peptide peptidomimetics
|
|
RU2221552C2
(ru)
|
1998-11-13 |
2004-01-20 |
Джаго Рисерч Аг |
Сухой порошок для ингаляции
|
|
CN100370990C
(zh)
|
1998-12-24 |
2008-02-27 |
詹森药业有限公司 |
控释加兰他敏组合物
|
|
JP2001151673A
(ja)
|
1999-09-06 |
2001-06-05 |
Nikken Chem Co Ltd |
吸入用粉末製剤の製造方法
|
|
US20020107173A1
(en)
|
1999-11-04 |
2002-08-08 |
Lawrence Friedhoff |
Method of treating amyloid beta precursor disorders
|
|
US20020009491A1
(en)
|
2000-02-14 |
2002-01-24 |
Rothbard Jonathan B. |
Compositions and methods for enhancing drug delivery across biological membranes and tissues
|
|
ME00183B
(me)
|
2000-02-21 |
2011-02-10 |
Pharmexa As |
Novi postupak za deregulaciju amiloida
|
|
EP1284729A4
(en)
|
2000-04-13 |
2007-12-19 |
Mayo Foundation |
A- (BETA) -42 DECREASING MEDICINAL PRODUCTS
|
|
US20080021085A1
(en)
|
2000-04-13 |
2008-01-24 |
Mayo Foundation For Medical Education And Research |
Method of reducing abeta42 and treating diseases
|
|
PE20011227A1
(es)
|
2000-04-17 |
2002-01-07 |
Chiesi Farma Spa |
Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
|
|
AR035642A1
(es)
|
2000-05-26 |
2004-06-23 |
Pharmacia Corp |
Uso de una composicion de celecoxib para el alivio rapido del dolor
|
|
US20020016359A1
(en)
|
2000-06-29 |
2002-02-07 |
Hellberg Mark R. |
Compositions and methods of treating neurodegenerative diseases
|
|
US8519005B2
(en)
|
2000-07-27 |
2013-08-27 |
Thomas N. Thomas |
Compositions and methods to prevent toxicity of antiinflammatory agents and enhance their efficacy
|
|
FR2815030A1
(fr)
|
2000-10-05 |
2002-04-12 |
Lipha |
Derives nitroso de la diphenylamine, compositions pharmaceutiques les contenant et leur utilisation pour la preparation de medicaments
|
|
US6511960B2
(en)
|
2001-01-05 |
2003-01-28 |
Alphamed Pharmaceuticals Corp |
Cromolyn for eye and ear infections
|
|
JP4317955B2
(ja)
|
2001-04-23 |
2009-08-19 |
ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア |
アミロイド斑凝集阻害剤および診断用造影剤
|
|
WO2003045331A2
(en)
|
2001-11-29 |
2003-06-05 |
Emisphere Technologies, Inc. |
Formulations for oral administration of cromolyn sodium
|
|
WO2003095010A2
(en)
|
2002-05-10 |
2003-11-20 |
Oriel Therapeutics, Inc. |
Dry powder inhalers for use with piezoelectric polymer-driven delivery means, and associated blister package comprising a piezoelectric polymer material
|
|
WO2004071531A1
(en)
|
2003-02-13 |
2004-08-26 |
Licentia Oy |
Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of cerebral ischemia
|
|
EP1601379A1
(en)
*
|
2003-02-13 |
2005-12-07 |
Licentia OY |
Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of a patient subjected to thrombolyses
|
|
US20040223918A1
(en)
|
2003-05-07 |
2004-11-11 |
Chrysalis Technologies Incorporated |
Aerosolization of cromolyn sodium using a capillary aerosol generator
|
|
GB0321607D0
(en)
|
2003-09-15 |
2003-10-15 |
Vectura Ltd |
Manufacture of pharmaceutical compositions
|
|
US20070053843A1
(en)
|
2003-10-28 |
2007-03-08 |
Dawson Michelle L |
Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
|
|
GB0326632D0
(en)
|
2003-11-14 |
2003-12-17 |
Jagotec Ag |
Dry powder formulations
|
|
DE10355559A1
(de)
|
2003-11-21 |
2005-06-23 |
Orthogen Ag |
Transskin
|
|
US8088935B2
(en)
|
2003-12-23 |
2012-01-03 |
Ironwood Pharmaceuticals, Inc. |
Compounds and methods for the treatment of asthma
|
|
US20070093457A1
(en)
|
2004-02-11 |
2007-04-26 |
Nadir Arber |
Compositions for treatment of cancer and inflammation with curcumin and at least one nsaid
|
|
US20050182044A1
(en)
|
2004-02-17 |
2005-08-18 |
Bruinsma Gosse B. |
Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate
|
|
WO2006001877A2
(en)
|
2004-04-13 |
2006-01-05 |
Myriad Genetics, Inc. |
Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
|
|
CN101098678A
(zh)
|
2004-04-23 |
2008-01-02 |
锡德克斯公司 |
含有磺基烷基醚环糊精的dpi制剂
|
|
CN101035541B
(zh)
|
2004-08-30 |
2012-05-30 |
柳署弘 |
溶解的udca在局灶缺血模型中的神经保护作用
|
|
DE602005025391D1
(de)
*
|
2004-11-01 |
2011-01-27 |
Seo Hong Yoo |
Verfahren und zusammensetzungen zur verringerung der neurodegeneration bei amyotrophischer lateralsklerose
|
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
|
US20060240007A1
(en)
|
2005-04-22 |
2006-10-26 |
Genentech, Inc. |
Method for treating dementia or Alzheimer's disease
|
|
CA2609980C
(en)
|
2005-05-27 |
2015-10-13 |
Queen's University At Kingston |
Treatment of protein folding disorders
|
|
EP1973523A2
(en)
|
2005-12-15 |
2008-10-01 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
|
|
US8263645B2
(en)
|
2006-02-03 |
2012-09-11 |
Pari Pharma Gmbh |
Disodium cromoglycate compositions and methods for administering same
|
|
AR059356A1
(es)
|
2006-02-14 |
2008-03-26 |
Astrazeneca Ab |
Nuevos radioligandos
|
|
DE602007009807D1
(de)
|
2006-03-06 |
2010-11-25 |
Raqualia Pharma Inc |
Sulfonylbenzimidazolderivate
|
|
CN103054837A
(zh)
|
2006-03-09 |
2013-04-24 |
瓦拉塔药品公司 |
用于治疗蛋白积聚病症的环己烷多元醇制剂
|
|
EP2023919A4
(en)
|
2006-05-08 |
2010-12-22 |
Molecular Neuroimaging Llc |
COMPOUNDS AND AMYLOID PROBES FOR THERAPY AND IMAGING USES
|
|
US8445437B2
(en)
|
2006-07-27 |
2013-05-21 |
The Brigham And Women's Hospital, Inc. |
Treatment and prevention of cardiovascular disease using mast cell stabilizers
|
|
US20100173960A1
(en)
|
2006-09-21 |
2010-07-08 |
Antonio Cruz |
The Combination of a Cyclohexanehexol and a NSAID for the Treatment of Neurodegenerative Diseases
|
|
EP2091566A4
(en)
|
2006-11-24 |
2011-07-06 |
Waratah Pharmaceuticals Inc |
COMBINATION THERAPIES AGAINST ALZHEIMER DISEASE AND SIMILAR ILLNESSES
|
|
WO2008128981A1
(en)
|
2007-04-18 |
2008-10-30 |
Probiodrug Ag |
Nitrovinyl-diamine derivatives as glutaminyl cyclase inhibitors
|
|
WO2008131298A2
(en)
|
2007-04-18 |
2008-10-30 |
Elan Pharma International Limited |
Prevention and treatment of cerebral amyloid angiopathy
|
|
US7858803B2
(en)
|
2007-04-27 |
2010-12-28 |
The General Hospital Corporation |
Imaging tracers for early detection and treatment of amyloid plaques caused by Alzheimer's disease and related disorders
|
|
JP2010533181A
(ja)
|
2007-07-13 |
2010-10-21 |
アボツト・バイオテクノロジー・リミテツド |
ＴＮＦα阻害剤の肺投与のための方法及び組成物
|
|
GB0714134D0
(en)
|
2007-07-19 |
2007-08-29 |
Norton Healthcare Ltd |
Dry-powder medicament
|
|
ES2498040T3
(es)
|
2007-07-27 |
2014-09-24 |
Janssen Alzheimer Immunotherapy |
Tratamiento de enfermedades amiloidogénicas con anticuerpos anti-beta humanizados
|
|
JO3076B1
(ar)
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
|
EP3231804B1
(en)
|
2008-03-21 |
2021-03-03 |
The General Hospital Corporation |
Compounds and compositions for the detection and treatment of alzheimer's disease and related disorders
|
|
CN104127434B
(zh)
|
2008-04-29 |
2017-10-13 |
法奈科斯公司 |
使用唑尼沙胺和阿坎酸治疗阿尔茨海默病和相关病症的组合组合物
|
|
BRPI1007202A2
(pt)
|
2009-01-22 |
2016-02-23 |
Raqualia Pharma Inc |
composto de fórmula (i), composição farmacêutica, método para tratamento de condição mediada pela atividade do receptor cb2 em um indivíduo mamífero e uso de composto de fórmula (i)
|
|
US8381454B1
(en)
|
2009-01-23 |
2013-02-26 |
Markus R. Robinson |
Segmented, elongated, expandable, 4-season, double-walled, low-cost, rigid extruded plastic panel structures
|
|
US9925282B2
(en)
|
2009-01-29 |
2018-03-27 |
The General Hospital Corporation |
Cromolyn derivatives and related methods of imaging and treatment
|
|
CN102341391B
(zh)
*
|
2009-01-29 |
2015-08-19 |
通用医疗公司 |
色甘酸衍生物以及制备成像和治疗的药物中的应用
|
|
KR101579771B1
(ko)
|
2009-03-05 |
2015-12-28 |
애브비 인코포레이티드 |
Ｉｌ-17 결합 단백질
|
|
TW201036972A
(en)
|
2009-03-11 |
2010-10-16 |
Plexxikon Inc |
Compounds and uses thereof
|
|
US8377947B2
(en)
|
2009-03-16 |
2013-02-19 |
Chien-Hung Chen |
Treating alzheimer's disease and osteoporosis and reducing aging
|
|
ES2457442T3
(es)
|
2009-05-08 |
2014-04-25 |
Pari Pharma Gmbh |
Formulaciones farmacéuticas concentradas estabilizadoras de los mastocitos
|
|
AU2010281524A1
(en)
*
|
2009-08-06 |
2012-02-23 |
Neuraltus Pharmaceuticals, Inc. |
Treatment of macrophage-related disorders
|
|
BR112012006638B1
(pt)
|
2009-09-24 |
2020-05-26 |
Wista Laboratories Ltd. |
Forma c de di-hidrato de cloreto de metiltionínio, seu processo de preparação, e composição farmacêutica
|
|
EP2322163A1
(en)
|
2009-11-03 |
2011-05-18 |
Pharnext |
New therapeutics approaches for treating alzheimer disease
|
|
WO2011057199A1
(en)
|
2009-11-06 |
2011-05-12 |
Adenios, Inc. |
Compositions for treating cns disorders
|
|
WO2011066287A1
(en)
|
2009-11-30 |
2011-06-03 |
Eurand, Inc. |
Compressible-coated pharmaceutical compositions and tablets and methods of manufacture
|
|
US20110256064A1
(en)
|
2010-04-16 |
2011-10-20 |
Ac Immune, S.A. |
Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-like Proteins
|
|
WO2011136754A1
(en)
|
2010-04-26 |
2011-11-03 |
Mahmut Bilgic |
A medicament developed for the treatment of respiratory diseases
|
|
MX2013001636A
(es)
*
|
2010-08-12 |
2013-05-01 |
Revalesio Corp |
Composiciones y metodos para el tratamiento de taupatias
|
|
PL2621494T3
(pl)
|
2010-09-30 |
2019-04-30 |
Chiesi Farm Spa |
Zastosowanie stearynianu magnezu w preparatach w postaci suchego proszku do inhalacji
|
|
US20120121656A1
(en)
|
2010-11-15 |
2012-05-17 |
Revalesio Corporation |
Methods and compositions for protecting against neurotoxicity of a neurotoxic agent, and improving motor coordination associated with a neurodegenerative condition or disease
|
|
JP5898701B2
(ja)
|
2011-02-11 |
2016-04-13 |
ウィスタ ラボラトリーズ リミテッド |
フェノチアジンジアミニウム塩およびそれらの使用
|
|
BR112014024287A2
(pt)
|
2012-03-27 |
2018-05-08 |
Duke University |
composições e métodos para a prevenção e tratamento do derrame vascular induzido por mastócitos
|
|
BR112014029442A2
(pt)
|
2012-05-25 |
2017-06-27 |
Xlear Inc |
composições antimucosas à base de xilitol e métodos e composições relacionados
|
|
AU2013308519A1
(en)
*
|
2012-08-31 |
2015-04-09 |
The General Hospital Corporation |
Biotin complexes for treatment and diagnosis of Alzheimer's disease
|
|
RU2627591C2
(ru)
|
2012-10-23 |
2017-08-09 |
Тейдзин Фарма Лимитед |
Терапевтический или профилактический агент для синдрома распада опухоли
|
|
CN109846862A
(zh)
|
2012-10-25 |
2019-06-07 |
通用医疗公司 |
治疗阿尔茨海默病及相关疾病的组合疗法
|
|
US10058530B2
(en)
|
2012-10-25 |
2018-08-28 |
The General Hospital Corporation |
Combination therapies for the treatment of Alzheimer's disease and related disorders
|
|
MX381503B
(es)
|
2013-05-23 |
2025-03-12 |
Aztherapies Inc |
Métodos para la liberación de cromolina.
|
|
US10525005B2
(en)
|
2013-05-23 |
2020-01-07 |
The General Hospital Corporation |
Cromolyn compositions and methods thereof
|
|
CN104288168B
(zh)
*
|
2013-07-17 |
2017-08-18 |
吉林敖东洮南药业股份有限公司 |
延龄草苷在制备用于治疗和/或预防小胶质细胞介导的疾病的药物中的用途
|
|
EP3060205A4
(en)
*
|
2013-10-22 |
2017-06-28 |
The General Hospital Corporation |
Cromolyn derivatives and related methods of imaging and treatment
|
|
AU2015213678C1
(en)
|
2014-02-10 |
2019-03-21 |
Respivant Sciences Gmbh |
Mast cell stabilizers treatment for systemic disorders
|
|
EP3104854B1
(en)
*
|
2014-02-10 |
2020-04-08 |
Respivant Sciences GmbH |
Mast cell stabilizers for lung disease treatment
|
|
EA201791110A1
(ru)
|
2014-11-21 |
2017-11-30 |
Биохэвен Фармасьютикэл Холдинг Компани Лтд. |
Сублингвальное введение рилузола
|
|
WO2016196401A1
(en)
|
2015-05-29 |
2016-12-08 |
The Texas A&M University System |
Antimicrobial and anti-inflammatory compositions
|
|
US10265296B2
(en)
|
2015-08-07 |
2019-04-23 |
Respivant Sciences Gmbh |
Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
|
|
US10238625B2
(en)
|
2015-08-07 |
2019-03-26 |
Respivant Sciences Gmbh |
Methods for the treatment of mast cell related disorders with mast cell stabilizers
|
|
EP3368032A1
(en)
*
|
2015-10-28 |
2018-09-05 |
AB Science |
Use of masitinib and other mast cell inhibitors for treatment of parkinson's disease
|
|
CA3005887A1
(en)
*
|
2015-11-19 |
2017-05-26 |
Aztherapies, Inc. |
Methods for treating alzheimer's disease and related disorders
|
|
CA3005909A1
(en)
|
2015-11-23 |
2017-06-01 |
Aztherapies, Inc. |
Compositions and methods for treating ischemic stroke
|
|
CA3018635C
(en)
*
|
2016-03-25 |
2023-09-26 |
Ab Science |
Use of masitinib for treatment of an amyotrophic lateral sclerosis patient subpopulation
|
|
WO2018045217A1
(en)
|
2016-08-31 |
2018-03-08 |
The General Hospital Corporation |
Macrophages/microglia in neuro-inflammation associated with neurodegenerative diseases
|
|
JP2019529541A
(ja)
|
2016-09-08 |
2019-10-17 |
エマーゴ セラピューティクス，インク． |
高サイトカイン血症及びウィルス感染の処置の為の肥満細胞安定剤
|
|
EP3654946A4
(en)
|
2017-07-20 |
2021-04-21 |
AZTherapies, Inc. |
CROMOLYNE SODIUM AND IBUPROFEN POWDER FORMULATIONS
|
|
CN108164409B
(zh)
|
2018-01-24 |
2021-06-18 |
温州医科大学 |
一种2-亚苄基-1-茚酮类似物及应用
|
|
AU2019251191A1
(en)
|
2018-04-09 |
2020-10-29 |
The General Hospital Corporation |
Combination therapies for the treatment of amyotropic lateral sclerosis and related disorders
|
|
CN108403708B
(zh)
|
2018-05-22 |
2019-06-14 |
滨州医学院 |
秦皮苷在制备预防或治疗急性呼吸窘迫综合征药物中的应用
|
|
CN113038944A
(zh)
|
2018-07-02 |
2021-06-25 |
通用医疗公司 |
色甘酸钠和α-乳糖的粉末化制剂
|
|
WO2020051322A1
(en)
|
2018-09-05 |
2020-03-12 |
The General Hospital Corporation |
Methods of treating cytokine release syndrome
|
|
MX2021006869A
(es)
|
2018-12-10 |
2021-07-02 |
Massachusetts Gen Hospital |
Esteres de cromolin y usos de los mismos.
|
|
WO2021207060A1
(en)
|
2020-04-06 |
2021-10-14 |
The General Hospital Corporation |
Methods of treatment of coronavirus-induced inflammation conditions
|
|
WO2021248022A1
(en)
|
2020-06-04 |
2021-12-09 |
The General Hospital Corporation |
Methods of treating a coronavirus infection
|
|
WO2022146914A1
(en)
|
2020-12-28 |
2022-07-07 |
The General Hospital Corporation |
Cromolyn derivatives and uses thereof
|